Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses

K Peng, Y Zheng, W Xia, ZW Mao - Chemical Society Reviews, 2023 - pubs.rsc.org
The great clinical success of cisplatin and its derivatives has convinced people that metal
complexes could play a more significant role in human cancer therapy. However, targeting …

Lactate in the tumour microenvironment: From immune modulation to therapy

ZH Wang, WB Peng, P Zhang, XP Yang, Q Zhou - EBioMedicine, 2021 - thelancet.com
Disordered metabolic states, which are characterised by hypoxia and elevated levels of
metabolites, particularly lactate, contribute to the immunosuppression in the tumour …

Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma

G Lu, X Wang, F Li, S Wang, J Zhao, J Wang… - Nature …, 2022 - nature.com
Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few
treatment options. Here, building on the observation of elevated lactate (LA) in resected …

PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of …

L Wang, S Li, H Luo, Q Lu, S Yu - Journal of Experimental & Clinical …, 2022 - Springer
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the ninth member of
the proprotein convertase family that regulates lipoprotein homeostasis and altered PCSK9 …

Next-generation characterization of the cancer cell line encyclopedia

M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov… - Nature, 2019 - nature.com
Large panels of comprehensively characterized human cancer models, including the
Cancer Cell Line Encyclopedia (CCLE), have provided a rigorous framework with which to …

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

S Han, Y Liu, SJ Cai, M Qian, J Ding, M Larion… - British journal of …, 2020 - nature.com
Isocitrate dehydrogenase (IDH) enzymes catalyse the oxidative decarboxylation of isocitrate
and therefore play key roles in the Krebs cycle and cellular homoeostasis. Major advances …

R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis

Y Qing, L Dong, L Gao, C Li, Y Li, L Han, E Prince… - Molecular cell, 2021 - cell.com
Summary R-2-hydroxyglutarate (R-2HG), a metabolite produced by mutant isocitrate
dehydrogenases (IDHs), was recently reported to exhibit anti-tumor activity. However, its …

Renal cell carcinoma as a metabolic disease: an update on main pathways, potential biomarkers, and therapeutic targets

NA di Meo, F Lasorsa, M Rutigliano, D Loizzo… - International Journal of …, 2022 - mdpi.com
Clear cell renal cell carcinoma (ccRCC) is the most frequent histological kidney cancer
subtype. Over the last decade, significant progress has been made in identifying the genetic …

3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs

AS Nunes, AS Barros, EC Costa… - Biotechnology and …, 2019 - Wiley Online Library
Three‐dimensional cell culture models, such as spheroids, can be used in the process of the
development of new anticancer agents because they are able to closely mimic the main …

[HTML][HTML] The science and translation of lactate shuttle theory

GA Brooks - Cell metabolism, 2018 - cell.com
Once thought to be a waste product of anaerobic metabolism, lactate is now known to form
continuously under aerobic conditions. Shuttling between producer and consumer cells …